Platinum OpinionCombination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade
References (10)
- et al.
Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia
J Urol
(2014) - et al.
The prescribing cascade revisited
Lancet
(2017) - et al.
Review of sexual preservation after novel benign prostatic hyperplasia surgical treatment modalities from Food and Drug Administration clinical trials
Sex Med Rev
(2021) - et al.
A systematic review of patients’ values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms
Eur Urol
(2021) - et al.
Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management
J Urol
(2021)
There are more references available in the full text version of this article.
Cited by (0)
© 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.